Approval to initiate a Clinical Trial for Hibor 2006.06.23

 
(Hong Kong, 23 June 2006) - Lee's Pharmaceutical Holdings Limited (GEM Stock: 8221: Website: www.leespharm.com ) today announced that the application for a clinical study for the HIBOR® (Bemiparin Sodium) has been approved by the SFDA of China.
 
  Download  


© Lee's Pharmaceutical Holdings Limited     Terms of Use   |   Privacy Statement Designed by YSD